Status:
UNKNOWN
Evaluation of Post-covid 19 Patients Who Receive Ozonetheraphy With Thorax CT
Lead Sponsor:
Gaziosmanpasa Research and Education Hospital
Conditions:
Ozone Therapy for Covid 19 Pneumonia Patients
Eligibility:
All Genders
18-80 years
Brief Summary
It is known that enhances wound healing by oxidative stress and supports immune system besides it is cheap and has not any side effects. Aim of the study is to prevent pulmonary fibrosis by using ozon...
Detailed Description
The patients accepted with the diagnosis of pneumonia in Gaziosmanpaşa TREH, both in ICU and wards have treated with additional ozone therapy beside the normal treathments. In these patients the findi...
Eligibility Criteria
Inclusion
- over 18 years covid 19 pneumonia patients who have ground glass opacity on thorax CT, receiving ozone as adjuvant therapy.
Exclusion
- pregnant patients patients who doesnt treated with ozone(hyperthyroid,pulmonary hypertension, right ventricule failure,glucose 6 P dehydrogenase defficiency
Key Trial Info
Start Date :
September 2 2020
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 20 2021
Estimated Enrollment :
25 Patients enrolled
Trial Details
Trial ID
NCT04789395
Start Date
September 2 2020
End Date
December 20 2021
Last Update
March 9 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Gaziosmanpaşa TREH
Istanbul, Gaziosmanpaşa, Turkey (Türkiye), 34255